Sou Hu Cai Jing·2025-09-17 20:10Group 1 - The core point of the news is that southbound funds have reduced their holdings in Chunli Medical (01858.HK) by 171,200 shares on September 17, 2025, marking a total net reduction of 251,000 shares over the last five trading days and 2,212,200 shares over the last twenty trading days [1][2] - As of now, southbound funds hold 42,983,800 shares of Chunli Medical, which represents 45.17% of the company's total issued ordinary shares [1][2] Group 2 - Chunli Medical is primarily engaged in the research, development, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, while its spinal implant products include a full range of spinal fixation systems [2] - Chunli Medical's products are exported to various countries and regions across Asia, South America, Africa, Oceania, and Europe [2]